Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher A Miller

Showing results (171-180 of 235) with videos related to

Pageof 24
Sort By:
Cancer Cell|March 12, 2014
Functional heterogeneity of genetically defined subclones in acute myeloid leukemiaJeffery M Klco, David H Spencer, Christopher A Miller, et al.
Heart (British Cardiac Society)|May 3, 2023
Rationale and design of a randomised trial of trientine in patients with hypertrophic cardiomyopathyJohn Farrant, Susanna Dodd, Carly Vaughan, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 31, 2020
Remethylation of <i>Dnmt3a</i><sup>-/-</sup> hematopoietic cells is associated with partial correction of gene dysregulation and reduced myeloid skewingShamika Ketkar, Angela M Verdoni, Amanda M Smith, et al.
Blood|December 4, 2015
Rapid expansion of preexisting nonleukemic hematopoietic clones frequently follows induction therapy for de novo AMLTerrence N Wong, Christopher A Miller, Jeffery M Klco, et al.
JCI Insight|March 9, 2018
Subclones dominate at MDS progression following allogeneic hematopoietic cell transplantMeagan A Jacoby, Eric J Duncavage, Gue Su Chang, et al.
Blood|July 27, 2022
Proteomic and phosphoproteomic landscapes of acute myeloid leukemiaMichael H Kramer, Qiang Zhang, Robert Sprung, et al.
Nature|October 18, 2013
Mutational landscape and significance across 12 major cancer typesCyriac Kandoth, Michael D McLellan, Fabio Vandin, et al.
Cancer Immunology Research|February 6, 2026
Neoadjuvant endocrine treatment plus mammaglobin-A DNA vaccine induces antitumor immune responses in the primary tumor and peripheral blood of breast cancer patients: Insights from a phase 1b clinical trialRashmi Mishra, Foluso Ademuyiwa, Yilin Yang, et al.
Communications Biology|July 3, 2023
Genetic characterization of primary and metastatic high-grade serous ovarian cancer tumors reveals distinct features associated with survivalEmilee N Kotnik, Mary M Mullen, Nicholas C Spies, et al.
Genome Medicine|April 21, 2021
Optimized polyepitope neoantigen DNA vaccines elicit neoantigen-specific immune responses in preclinical models and in clinical translationLijin Li, Xiuli Zhang, Xiaoli Wang, et al.
Pageof 24

Showing results (171-180 of 235) with videos related to

Sort By:
Pageof 24
Cancer Cell|March 12, 2014
Functional heterogeneity of genetically defined subclones in acute myeloid leukemiaJeffery M Klco, David H Spencer, Christopher A Miller, et al.
Heart (British Cardiac Society)|May 3, 2023
Rationale and design of a randomised trial of trientine in patients with hypertrophic cardiomyopathyJohn Farrant, Susanna Dodd, Carly Vaughan, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 31, 2020
Remethylation of <i>Dnmt3a</i><sup>-/-</sup> hematopoietic cells is associated with partial correction of gene dysregulation and reduced myeloid skewingShamika Ketkar, Angela M Verdoni, Amanda M Smith, et al.
Blood|December 4, 2015
Rapid expansion of preexisting nonleukemic hematopoietic clones frequently follows induction therapy for de novo AMLTerrence N Wong, Christopher A Miller, Jeffery M Klco, et al.
JCI Insight|March 9, 2018
Subclones dominate at MDS progression following allogeneic hematopoietic cell transplantMeagan A Jacoby, Eric J Duncavage, Gue Su Chang, et al.
Blood|July 27, 2022
Proteomic and phosphoproteomic landscapes of acute myeloid leukemiaMichael H Kramer, Qiang Zhang, Robert Sprung, et al.
Nature|October 18, 2013
Mutational landscape and significance across 12 major cancer typesCyriac Kandoth, Michael D McLellan, Fabio Vandin, et al.
Cancer Immunology Research|February 6, 2026
Neoadjuvant endocrine treatment plus mammaglobin-A DNA vaccine induces antitumor immune responses in the primary tumor and peripheral blood of breast cancer patients: Insights from a phase 1b clinical trialRashmi Mishra, Foluso Ademuyiwa, Yilin Yang, et al.
Communications Biology|July 3, 2023
Genetic characterization of primary and metastatic high-grade serous ovarian cancer tumors reveals distinct features associated with survivalEmilee N Kotnik, Mary M Mullen, Nicholas C Spies, et al.
Genome Medicine|April 21, 2021
Optimized polyepitope neoantigen DNA vaccines elicit neoantigen-specific immune responses in preclinical models and in clinical translationLijin Li, Xiuli Zhang, Xiaoli Wang, et al.
Pageof 24